Johnson Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.54M Sell
23,570
-446
-2% -$153K 0.06% 160
2026
Q1
$8.45M Sell
24,016
-1,787
-7% -$637K 0.07% 148
2025
Q4
$8.45M Sell
25,803
-308
-1% -$97.7K 0.07% 137
2025
Q3
$7.37M Sell
26,111
-133
-0.5% -$38.6K 0.06% 144
2025
Q2
$7.33M Buy
26,244
+555
+2% +$157K 0.07% 142
2025
Q1
$8M Buy
25,689
+197
+0.8% +$58.2K 0.08% 130
2024
Q4
$6.64M Sell
25,492
-218
-0.8% -$64.7K 0.06% 139
2024
Q3
$8.28M Sell
25,710
-972
-4% -$318K 0.08% 128
2024
Q2
$8.34M Sell
26,682
-313
-1% -$92K 0.09% 124
2024
Q1
$7.68M Sell
26,995
-1,150
-4% -$336K 0.08% 131
2023
Q4
$8.11M Buy
28,145
+469
+2% +$128K 0.1% 124
2023
Q3
$7.44M Buy
27,676
+1,489
+6% +$372K 0.1% 119
2023
Q2
$5.81M Sell
26,187
-1,094
-4% -$254K 0.07% 134
2023
Q1
$6.6M Buy
27,281
+1,225
+5% +$301K 0.09% 124
2022
Q4
$6.84M Buy
26,056
+498
+2% +$133K 0.09% 121
2022
Q3
$5.76M Sell
25,558
-1,271
-5% -$308K 0.09% 125
2022
Q2
$6.53M Sell
26,829
-379
-1% -$92.9K 0.09% 125
2022
Q1
$6.58M Sell
27,208
-420
-2% -$96.5K 0.08% 132
2021
Q4
$6.21M Sell
27,628
-185
-0.7% -$39K 0.08% 135
2021
Q3
$5.91M Sell
27,813
-860
-3% -$198K 0.08% 134
2021
Q2
$6.99M Sell
28,673
-1,212
-4% -$298K 0.1% 120
2021
Q1
$7.44M Sell
29,885
-824
-3% -$197K 0.11% 112
2020
Q4
$7.06M Buy
30,709
+228
+0.7% +$52.6K 0.12% 102
2020
Q3
$7.75M Sell
30,481
-14
-0% -$3.47K 0.14% 96
2020
Q2
$7.19M Sell
30,495
-1,352
-4% -$308K 0.15% 97
2020
Q1
$6.46M Sell
31,847
-1,872
-6% -$409K 0.14% 101
2019
Q4
$8.13M Buy
33,719
+2,388
+8% +$526K 0.15% 100
2019
Q3
$6.06M Buy
31,331
+7,756
+33% +$1.49M 0.12% 116
2019
Q2
$4.34M Sell
23,575
-3,044
-11% -$545K 0.09% 135
2019
Q1
$5.06M Buy
26,619
+485
+2% +$92.6K 0.11% 125
2018
Q4
$5.09M Buy
26,134
+1,784
+7% +$348K 0.12% 119
2018
Q3
$5.05M Buy
24,350
+200
+0.8% +$39.4K 0.11% 125
2018
Q2
$4.46M Buy
24,150
+818
+4% +$145K 0.11% 123
2018
Q1
$3.98M Sell
23,332
-2,336
-9% -$429K 0.1% 126
2017
Q4
$4.46M Sell
25,668
-492
-2% -$87.1K 0.11% 124
2017
Q3
$4.88M Buy
26,160
+526
+2% +$93.2K 0.13% 117
2017
Q2
$4.42M Buy
25,634
+52
+0.2% +$8.46K 0.12% 116
2017
Q1
$4.2M Buy
25,582
+272
+1% +$45.2K 0.12% 122
2016
Q4
$3.7M Buy
25,310
+435
+2% +$65.5K 0.11% 125
2016
Q3
$4.15M Buy
24,875
+1,421
+6% +$240K 0.13% 116
2016
Q2
$3.57M Buy
23,454
+559
+2% +$86.9K 0.12% 131
2016
Q1
$3.43M Buy
22,895
+364
+2% +$54.1K 0.12% 129
2015
Q4
$3.66M Sell
22,531
-1,573
-7% -$247K 0.13% 120
2015
Q3
$3.33M Buy
24,104
+20
+0.1% +$3.15K 0.12% 126
2015
Q2
$3.7M Buy
24,084
+180
+0.8% +$28.8K 0.12% 123
2015
Q1
$3.82M Sell
23,904
-900
-4% -$142K 0.13% 120
2014
Q4
$3.95M Sell
24,804
-1,421
-5% -$221K 0.13% 116
2014
Q3
$3.68M Sell
26,225
-350
-1% -$45.7K 0.12% 113
2014
Q2
$3.15M Sell
26,575
-150
-0.6% -$17.4K 0.11% 110
2014
Q1
$3.3M Buy
26,725
+290
+1% +$35.2K 0.12% 104
2013
Q4
$3.02M Buy
26,435
+4,790
+22% +$545K 0.11% 114
2013
Q3
$2.42M Buy
21,645
+35
+0.2% +$3.79K 0.1% 125
2013
Q2
$2.13M Buy
+21,610
New +$2.24M 0.09% 122

Other funds holding AMGN

Johnson Investment Counsel's AMGN Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Amgen (AMGN) stake by 1.9% in Q2 2026, selling an estimated $153K and leaving 23,570 shares worth $8.54M. The position accounts for 0.06% of the portfolio, ranked #160.

Johnson Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Johnson Investment Counsel held 23,570 shares of Amgen worth $8.54M as of Q2 2026.
  • Johnson Investment Counsel sold 446 Amgen shares in Q2 2026, an estimated $153K.
  • Amgen made up 0.06% of Johnson Investment Counsel's portfolio in Q2 2026, its #160 holding.
  • Johnson Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.